Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Asselain

Showing results (151-160 of 227) with videos related to

Pageof 23
Sort By:
Revue Des Maladies Respiratoires|January 1, 1984
[Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer]G Decroix, C Chastang, B Lebeau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Neoadjuvant chemotherapy in operable breast cancerS M Scholl, B Asselain, T Palangie, et al.
Journal Francais D'Ophtalmologie|October 7, 2005
[Functional results of retinoblastoma treatment with local treatment used in isolation or associated with chemotherapy]L Desjardins, M Charif Chefchaouni, L Lumbroso, et al.
Cancer|January 1, 1996
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsX Sastre-Garau, M Jouve, B Asselain, et al.
The British Journal of Ophthalmology|January 30, 1999
Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary resultsC Levy, F Doz, E Quintana, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors in inflammatory breast cancer and therapeutic implicationsT Palangie, V Mosseri, J Mihura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapyS Chevillard, J Lebeau, P Pouillart, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancerJ Y Pierga, M Jouve, B Asselain, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 1994
Simultaneous bilateral breast carcinomas: a retrospective review of 149 casesA de la Rochefordiere, B Asselain, S Scholl, et al.
Revue Des Maladies Respiratoires|November 8, 2017
[First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals]M Grivaux, F Goupil, B Asselain, et al.
Pageof 23

Showing results (151-160 of 227) with videos related to

Sort By:
Pageof 23
Revue Des Maladies Respiratoires|January 1, 1984
[Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer]G Decroix, C Chastang, B Lebeau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Neoadjuvant chemotherapy in operable breast cancerS M Scholl, B Asselain, T Palangie, et al.
Journal Francais D'Ophtalmologie|October 7, 2005
[Functional results of retinoblastoma treatment with local treatment used in isolation or associated with chemotherapy]L Desjardins, M Charif Chefchaouni, L Lumbroso, et al.
Cancer|January 1, 1996
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsX Sastre-Garau, M Jouve, B Asselain, et al.
The British Journal of Ophthalmology|January 30, 1999
Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary resultsC Levy, F Doz, E Quintana, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors in inflammatory breast cancer and therapeutic implicationsT Palangie, V Mosseri, J Mihura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapyS Chevillard, J Lebeau, P Pouillart, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancerJ Y Pierga, M Jouve, B Asselain, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 1994
Simultaneous bilateral breast carcinomas: a retrospective review of 149 casesA de la Rochefordiere, B Asselain, S Scholl, et al.
Revue Des Maladies Respiratoires|November 8, 2017
[First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals]M Grivaux, F Goupil, B Asselain, et al.
Pageof 23